Pharmastute provides extensive in-licensing consulting between large, medium, and small research firms. During the research and development phase of many products, especially pharmaceuticals, the cost involved can be extremely high, causing companies to have second thoughts about the possibility of developing a drug. In-licensing is something many of the pharmaceutical giants eye at on a regular basis. Our in-licensing services are built on a partnership concept that develops a strong understanding between two firms that have shared intentions, goals or fields of interest. Further, the profit sharing that happens between the two companies can be a very lucrative investment. It is important that the companies should be capable to identify, evaluate and negotiate deals. We help companies of all sizes to identify and evaluate in-licensing opportunities at every phase of development from conception to market-ready product. Following are the steps involved during our in-licensing analysis:

• Identifying target SME's and research groups
• Patent Value analysis
• Assessing Market value and License fee structuring
• Deal Negotiation and Execution

The first step is to identify the research firms which are interested in Out-Licensing their technology. Secondly, the strength of the provided patent is assessed by performing a prior art search in the technology domain and by evaluating the prosecution history. Our in-house research team does market research to assess the market size for similar existing products with the help of related technology which in turn helps to structure the licensing fee. After this research process, the key contacts in the targeted companies are identified and negotiations are initiated which finally leads to a successful deal.

       Generally, out-licensing involves a process in which a company would offer their technology or product to another company for a license fee. The company which buys the license would pay an upfront payment and later on a monthly, quarterly or yearly license fee. Our out-licensing services help to ease your whole process by following a simple methodology through:

• IP Portfolio analysis
• Identifying target molecule/product
• Identifying Target companies/R & D Companies
• Assessing market size and license fee structuring
• Deal Negotiation and execution

A thorough analysis of client's IP portfolio is done which helps in grouping the technology and domain. The target molecule or product of interest in which the technology can be implemented is identified. Our business research team identifies firms with similar molecule in the research pipeline. The market size for similar products in the market is analyzed which helps in structuring the licensing fee. Finally the key contacts in the target companies are identified and negotiations are initiated.